{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:53:26Z","timestamp":1781571206429,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.humimm.2024.110768","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:21:46Z","timestamp":1709364106000},"page":"110768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current approaches for risk assessment of intestinal transplant patients: A view from the histocompatibility laboratory"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-1924","authenticated-orcid":false,"given":"Qingyong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ganoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Ruy J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2024.110768_b0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOT.0000000000000608","article-title":"Current outcomes after pediatric and adult intestinal transplantation","volume":"24","author":"Amin","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2024.110768_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MOT.0000000000000853","article-title":"Donor-specific antibody and sensitized patients in intestinal transplantation","volume":"26","author":"Matsumoto","year":"2021","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2024.110768_b0020","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J. Heart Lung Transpl."},{"issue":"13","key":"10.1016\/j.humimm.2024.110768_b0030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.humimm.2024.110768_b0035","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.21037\/jtd-2021-21","article-title":"Approaching the sensitized lung patient: risk assessment for donor acceptance","volume":"13","author":"Mangiola","year":"2021","journal-title":"J Thorac Dis."},{"issue":"14","key":"10.1016\/j.humimm.2024.110768_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.humimm.2024.110768_b0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-198911000-00022","article-title":"The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities","volume":"48","author":"Bray","year":"1989","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2024.110768_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101629","article-title":"Implementing virtual crossmatch based diagnostic management teams in human leukocyte antigen laboratories and transplant programs","volume":"73","author":"Wade","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2024.110768_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15937","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2019 Working Group Meeting Report","author":"Tambur","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2024.110768_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2019.12.006","article-title":"Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing","author":"Dean","year":"2020","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/hbsn.2019.01.01","article-title":"Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff","volume":"8","author":"McCaughan","year":"2019","journal-title":"Hepatobil. Surg Nutr."},{"key":"10.1016\/j.humimm.2024.110768_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humimm.2023.07.029","article-title":"O20 Presumed or functional epitope: the need for confirmation with cell-based assays","volume":"84","author":"Xu","year":"2023","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2024.110768_b0080","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1111\/ajt.16753","article-title":"Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination","volume":"21","author":"Xu","year":"2021","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"9","key":"10.1016\/j.humimm.2024.110768_b0085","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.4049\/jimmunol.175.9.5950","article-title":"Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies","volume":"175","author":"Mulder","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2024.110768_b0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.humimm.2019.07.294","article-title":"Abolishing serum interference in detection of HLA antibodies: who, How, When and Why?","volume":"80","author":"Greenshields","year":"2019","journal-title":"Hum Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110768_b0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2014a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"issue":"1S Suppl 1","key":"10.1016\/j.humimm.2024.110768_b0100","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0000000000001817","article-title":"HLA diagnostics: Evaluating DSA strength by titration","volume":"102","author":"Tambur","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.humimm.2024.110768_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002572","article-title":"Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: a systematic review and meta-analysis","volume":"15","author":"Bouquegneau","year":"2018","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2024.110768_b0115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver\/kidney transplants","volume":"11","author":"Dar","year":"2011","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"4","key":"10.1016\/j.humimm.2024.110768_b0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/TP.0000000000001391","article-title":"Prevalence and clinical impact of donor-specific alloantibody among intestinal transplant recipients","volume":"101","author":"Cheng","year":"2017","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.humimm.2024.110768_b0125","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/lt.25323","article-title":"Donor-specific antibodies in pediatric intestinal and multivisceral transplantation: the role of liver and human leukocyte antigen mismatching","volume":"24","author":"Talayero","year":"2018","journal-title":"Liver Transpl."},{"issue":"11","key":"10.1016\/j.humimm.2024.110768_b0130","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/j.1600-6143.2012.04237.x","article-title":"Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver","volume":"12","author":"Abu-Elmagd","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"1","key":"10.1016\/j.humimm.2024.110768_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/gastro\/gox043","article-title":"Liver-inclusive intestinal transplantation results in decreased alloimmune-mediated rejection but increased infection","volume":"6","author":"Wu","year":"2018","journal-title":"Gastroenterol Rep (oxf)."},{"issue":"6","key":"10.1016\/j.humimm.2024.110768_b0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0041-1345(00)01181-7","article-title":"The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival","volume":"32","author":"Bond","year":"2000","journal-title":"Transpl. Proc."},{"issue":"12","key":"10.1016\/j.humimm.2024.110768_b0145","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/TP.0b013e31820000a1","article-title":"Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants","volume":"90","author":"Farmer","year":"2010","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1016\/j.humimm.2024.110768_b0150","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1600-6143.2012.04238.x","article-title":"Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching","volume":"12","author":"Hawksworth","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"2","key":"10.1016\/j.humimm.2024.110768_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOT.0000000000000393","article-title":"The impact of antibodies and virtual crossmatching on intestinal transplant outcomes","volume":"22","author":"Cheng","year":"2017","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"11","key":"10.1016\/j.humimm.2024.110768_b0160","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1111\/ajt.15414","article-title":"Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation","volume":"19","author":"Senev","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2024.110768_b0165","author":"Iasella","year":"2020","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2024.110768_b0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MOT.0000000000000619","article-title":"Donor-specific antibody management in intestine transplantation: hope for improving the long-term durability of the intestine allograft?","volume":"24","author":"Hawksworth","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2024.110768_b0175","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12847","article-title":"Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children","volume":"21","author":"Petit","year":"2017","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.humimm.2024.110768_b0180","unstructured":"K. Klein, M. Keck, E. Langewisch, S. Merani, K. Hitchman, M. Leick, Evaluation of serial monitoring of donor-specific antibodies in pediatric and adult intestinal\/multivisceral transplant recipients. Pediatric transplantation.n\/a(n\/a):e14638."},{"key":"10.1016\/j.humimm.2024.110768_b0185","article-title":"Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience","volume":"10","author":"Lasa-L\u00e1zaro","year":"2022","journal-title":"Front Pediatr."},{"issue":"6","key":"10.1016\/j.humimm.2024.110768_b0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0b013e318229f752","article-title":"Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation","volume":"92","author":"Tsai","year":"2011","journal-title":"Transplantation"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:02:35Z","timestamp":1781568155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0198885924000247"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110768","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current approaches for risk assessment of intestinal transplant patients: A view from the histocompatibility laboratory","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110768"}}